Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Research article

HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study

Authors: Dovilė Ražanskaitė-Virbickienė, Evalda Danytė, Rimantas Žalinkevičius

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

Increased urinary albumin excretion rate is the earliest clinical manifestation of diabetic nephropathy. The development of microalbuminuria in patients with type 1 diabetes mellitus (T1D) usually begins 5 to 15 years after the onset of diabetes. The rate of progression of diabetic nephropathy varies considerably among patients and not always can be explained solely by glycaemic control. The evidence suggests that genetic susceptibility may play a role in the development of diabetes microvascular complications, besides the presence of such risk factors as hyperglycaemia, hypertension, dyslipidaemia and smoking. The aim of the study was to evaluate a link between known genetic risk factors for type 1 diabetes mellitus (HLA-DR3/DR4) and microalbuminuria among patients with the same durations of diabetes.

Methods

Ninety-nine patients with T1D at the age 18–35 years were recruited for the study. The urine albumin excretion rate was normal when <30 mg/24 h; microalbuminuria 30–300 mg/24 h. Genotypes were investigated in 39 patients with normal albumin excretion rate and duration of diabetes 13.46 ± 3.72 years and in 60 patients with microalbuminuria and duration of diabetes 15.28 ± 4.08 years (p = 0.11). Genetic typing of DR3 and DR4 antigens successfully was performed for 99 subjects. Statistical analysis was performed using SPSS v. 20.0.

Results

Genotyping of 99 patients with T1D was performed: no DR3 and DR4 risk alleles were found in 22 (22.22 %) cases, DR3 alleles were present in 47 (47.48 %) cases, DR4 alleles in 25 (25.25 %) cases, and DR3/DR4 alleles in 5 (5.05 %) cases. The highest 24 h albumin excretion rate was found in patients with DRB1 gene expressed DR3 risk alleles group, the lowest - in patients with DRB1 gene with no expression of both DR3 and DR4 antigen. We confirmed the 1.87 (p = 0.021) increased relative risk for microalbuminuria in patients with DR3/DR3 alleles and same duration of diabetes. The distribution of DR3 and DR4 risk alleles was not associated with cardiovascular autonomic neuropathy both in patients with normal albumin excretion rate and microalbuminuria (1.6 vs 2.1; p = 0.21).

Conclusions

The 1.87 (p = 0.021) increased relative risk for microalbuminuria was found in patients with DR3/DR3 alleles and the same duration of diabetes.
Literature
1.
go back to reference Brorsson C, Hansen NT, Lage K, Bergholdt R, Brunak S, Pociot F. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data. Diabetes Obes Metab. 2009;11 Suppl 1:60–6.CrossRefPubMedPubMedCentral Brorsson C, Hansen NT, Lage K, Bergholdt R, Brunak S, Pociot F. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data. Diabetes Obes Metab. 2009;11 Suppl 1:60–6.CrossRefPubMedPubMedCentral
2.
go back to reference Kazanavicius G, Barsiene L, Cibas P, Danytė E, Daugintyte-Petrosiene L, Graziene A. Endocrinology. 2009:90–97; 106–107; 167–174. Kazanavicius G, Barsiene L, Cibas P, Danytė E, Daugintyte-Petrosiene L, Graziene A. Endocrinology. 2009:90–97; 106–107; 167–174.
3.
go back to reference Groop PH, Thomas MC, Moran JL, Waden J, Thorn LM, Makinen VP, Rosengard-Barlund M, Saraheimo M, Hietala K, Heikkila O, et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009;58(7):1651–8. Groop PH, Thomas MC, Moran JL, Waden J, Thorn LM, Makinen VP, Rosengard-Barlund M, Saraheimo M, Hietala K, Heikkila O, et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009;58(7):1651–8.
4.
go back to reference Maser RS, Lenhard MJ, DeCherney GS. Cardiovascular autonomic neuropathy: the clinical significance of its determination. Endocrinologist. 2000;10:27–33.CrossRef Maser RS, Lenhard MJ, DeCherney GS. Cardiovascular autonomic neuropathy: the clinical significance of its determination. Endocrinologist. 2000;10:27–33.CrossRef
5.
go back to reference Vergouwe Y, Soedamah-Muthu SS, Zgibor J, Chaturvedi N, Forsblom C, Snell-Bergeon JK, Maahs DM, Groop PH, Rewers M, Orchard TJ, et al. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia. 2010;53(2):254–62. Vergouwe Y, Soedamah-Muthu SS, Zgibor J, Chaturvedi N, Forsblom C, Snell-Bergeon JK, Maahs DM, Groop PH, Rewers M, Orchard TJ, et al. Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia. 2010;53(2):254–62.
6.
go back to reference Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ. 2004;328(7448):1105. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ. 2004;328(7448):1105.
7.
go back to reference Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7(6):930–7.PubMed Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7(6):930–7.PubMed
8.
go back to reference Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group. Diabet Med. 1999;16(11):918–25. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group. Diabet Med. 1999;16(11):918–25.
9.
go back to reference Correa-Giannella ML, Vieira SM. [Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus]. Arq Bras Endocrinol Metabol. 2008;52(2):375–86.CrossRefPubMed Correa-Giannella ML, Vieira SM. [Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus]. Arq Bras Endocrinol Metabol. 2008;52(2):375–86.CrossRefPubMed
10.
go back to reference Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet. 1996;59(5):1134–48.PubMedPubMedCentral Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet. 1996;59(5):1134–48.PubMedPubMedCentral
12.
go back to reference WHO Expert Committe on Diabetes Mellitus. Second report. Technical Report series no 1985, 742. Geneva: WHO. 1980;646:1–80. WHO Expert Committe on Diabetes Mellitus. Second report. Technical Report series no 1985, 742. Geneva: WHO. 1980;646:1–80.
13.
go back to reference Mogensen CE, Hansen KW, Nielsen S, Pedersen MM, Rehling M, Schmitz A. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease–reproducibility, progression, and efficacy of antihypertensive intervention. Am J Kidney Dis. 1993;22(1):174–87.CrossRefPubMed Mogensen CE, Hansen KW, Nielsen S, Pedersen MM, Rehling M, Schmitz A. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease–reproducibility, progression, and efficacy of antihypertensive intervention. Am J Kidney Dis. 1993;22(1):174–87.CrossRefPubMed
14.
go back to reference Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 2005;9(30):iii-vi, xiii-163. Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 2005;9(30):iii-vi, xiii-163.
15.
go back to reference Bogdanovic R. Diabetic nephropathy in children and adolescents. Pediatr Nephrol. 2008;23(4):507–25.CrossRefPubMed Bogdanovic R. Diabetic nephropathy in children and adolescents. Pediatr Nephrol. 2008;23(4):507–25.CrossRefPubMed
16.
go back to reference Chobanian MC, Chevalier RL, Sturgill BC, Bolton WK. Early onset of clinical diabetic nephropathy in children–a new subgroup? Int J Pediatr Nephrol. 1984;5(1):23–9.PubMed Chobanian MC, Chevalier RL, Sturgill BC, Bolton WK. Early onset of clinical diabetic nephropathy in children–a new subgroup? Int J Pediatr Nephrol. 1984;5(1):23–9.PubMed
18.
go back to reference Rossing P. Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. Diabetologia. 2006;49(1):11–9.CrossRefPubMed Rossing P. Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. Diabetologia. 2006;49(1):11–9.CrossRefPubMed
19.
go back to reference Li Y, Tang K, Zhang Z, Zhang M, Zeng Z, He Z, He L, Wan C. Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. Mol Biol Rep. 2011;38(5):3243–52. Li Y, Tang K, Zhang Z, Zhang M, Zeng Z, He Z, He L, Wan C. Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. Mol Biol Rep. 2011;38(5):3243–52.
20.
go back to reference Chandy A, Pawar B, John M, Isaac R. Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications. Saudi J Kidney Dis Transpl. 2008;19(6):924–8.PubMed Chandy A, Pawar B, John M, Isaac R. Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications. Saudi J Kidney Dis Transpl. 2008;19(6):924–8.PubMed
21.
go back to reference Mollsten A, Marklund SL, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes. 2007;56(1):265–9. Mollsten A, Marklund SL, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes. 2007;56(1):265–9.
23.
go back to reference Agardh E, Gaur LK, Lernmark A, Agardh CD. HLA-DRB1, -DQA1, and -DQB1 subtypes or ACE gene polymorphisms do not seem to be risk markers for severe retinopathy in younger Type 1 diabetic patients. J Diabetes Complications. 2004;18(1):32–6.CrossRefPubMed Agardh E, Gaur LK, Lernmark A, Agardh CD. HLA-DRB1, -DQA1, and -DQB1 subtypes or ACE gene polymorphisms do not seem to be risk markers for severe retinopathy in younger Type 1 diabetic patients. J Diabetes Complications. 2004;18(1):32–6.CrossRefPubMed
24.
go back to reference Saner B, Bonney E, Barbosa J. HLA-DR antigens and diabetic nephropathy. Diabetologia. 2004;25(5):452.CrossRef Saner B, Bonney E, Barbosa J. HLA-DR antigens and diabetic nephropathy. Diabetologia. 2004;25(5):452.CrossRef
25.
go back to reference Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffman M, McDuffie RS, Jr., Hamman RF, Klingensmith G, Eisenbarth GS et, al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996;39(7):807–12. Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffman M, McDuffie RS, Jr., Hamman RF, Klingensmith G, Eisenbarth GS et, al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996;39(7):807–12.
26.
go back to reference Sheild JPH, Wadsworth EJK, Baum JD. The genetic contribution to disease pathogenesis inchildhood diabetes is greatest in the very young. Diabet Med. 1995;12:377-79. Sheild JPH, Wadsworth EJK, Baum JD. The genetic contribution to disease pathogenesis inchildhood diabetes is greatest in the very young. Diabet Med. 1995;12:377-79.
27.
go back to reference Barbosa J, Saner B. Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia. 1984;27(5):487–92.CrossRefPubMed Barbosa J, Saner B. Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia. 1984;27(5):487–92.CrossRefPubMed
28.
go back to reference Chowdhury TA, Dyer PH, Mijovic CH, Dunger DB, Barnett AH, Bain SC. Human leucocyte antigen and insulin gene regions and nephropathy in type I diabetes. Diabetologia. 1999;42(8):1017–20.CrossRefPubMed Chowdhury TA, Dyer PH, Mijovic CH, Dunger DB, Barnett AH, Bain SC. Human leucocyte antigen and insulin gene regions and nephropathy in type I diabetes. Diabetologia. 1999;42(8):1017–20.CrossRefPubMed
29.
go back to reference Ronningen KS, Bangstad HJ, Undlien DE, Thorsby E. Influence of genetic factors (HLA class II genes, insulin-gene region polymorphisms) and metabolic control on the development of diabetic nephropathy. Diabetes Res. 1993;23(1):31–40.PubMed Ronningen KS, Bangstad HJ, Undlien DE, Thorsby E. Influence of genetic factors (HLA class II genes, insulin-gene region polymorphisms) and metabolic control on the development of diabetic nephropathy. Diabetes Res. 1993;23(1):31–40.PubMed
30.
go back to reference Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Christy M, Borch-Johnsen K, Parving HH, Deckert T, Molsted-Pedersen L, et al. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens. 1986;28(4):237–44. Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Christy M, Borch-Johnsen K, Parving HH, Deckert T, Molsted-Pedersen L, et al. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens. 1986;28(4):237–44.
31.
go back to reference Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, Hancock LN, Cleary PA, Mueller PW. Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes. 2008;57(2):518–22. Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, Hancock LN, Cleary PA, Mueller PW. Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study. Diabetes. 2008;57(2):518–22.
Metadata
Title
HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study
Authors
Dovilė Ražanskaitė-Virbickienė
Evalda Danytė
Rimantas Žalinkevičius
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0252-4

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue